Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
27%
OVERLAP
BY WEIGHT
21
# OF OVERLAPPING
HOLDINGS
FTXH
51
HOLDINGS
44%
ALSO IN WDNA
WDNA
85
HOLDINGS
27%
ALSO IN FTXH
SECTOR DRIFT (FTXH minus WDNA)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in FTXH |
Weight in WDNA |
Overlap | |
|---|---|---|---|---|
 |
ELI LILLY & CO | 4.4% | 3.1% | 3.1% |
|
JOHNSON & JOHNSON | 7.0% | 2.7% | 2.7% |
|
PFIZER INC | 6.2% | 2.4% | 2.4% |
|
UNITED THERAPEUTICS CORP | 3.3% | 2.3% | 2.3% |
|
AMGEN INC | 3.4% | 2.2% | 2.2% |
FTXH Overweight Relative to WDNA
|
MERCK & CO. INC. | 7.3% |
|
ABBVIE INC | 6.3% |
|
BRISTOL-MYERS SQUIBB CO | 6.1% |
|
JOHNSON & JOHNSON | 4.3% |
|
CARDINAL HEALTH INC | 4.1% |
|
PFIZER INC | 3.8% |
|
VIATRIS, INC. | 3.7% |
|
BIOGEN IDEC INC | 3.5% |
|
REGENERON PHARMACEUTICALS | 3.0% |
 |
JAZZ PHARMACEUTICALS PLC | 2.3% |
FTXH Underweight Relative to WDNA
|
NATERA INC | -2.9% |
|
MODERNA, INC. | -2.6% |
|
STOKE THERAPEUTICS, INC. | -2.5% |
|
REGENXBIO, INC. | -2.3% |
 |
BIONTECH SE SPONSORED ADR | -2.3% |
|
AMICUS THERAPEUTICS INC | -2.2% |
 |
NOVO NORDISK A/S-B | -2.2% |
 |
ASTRAZENECA PLC-SPONS ADR | -2.1% |
|
BEAM THERAPEUTICS, INC. | -2.1% |
|
CRISPR THERAPEUTICS AG | -2.1% |